Drug Type Autologous CAR-T |
Synonyms CAR-GPRC5D |
Target |
Mechanism GPRC5D modulators(G-protein coupled receptor family C group 5member D modulators), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plasma Cell Leukemia | Phase 1 | CN | 30 Mar 2023 | |
Plasma cell myeloma refractory | Phase 1 | CN | 30 Mar 2023 | |
Relapse multiple myeloma | Phase 1 | CN | 30 Mar 2023 |